Table 1.
BLBC (n = 63) n (%) |
QNBC (n = 43) n (%) |
p-value* | |
---|---|---|---|
Age (years) | 58 (16) | 57 (12) | 0.78 |
Menstrual status | 0.49 | ||
None | 13 (45) | 7 (32) | |
Physiological | 11 (38) | 12 (54) | |
Post-surgery | 5 (17) | 3 (14) | |
Site | 0.14 | ||
Dx | 33 (59) | 17 (39) | |
Sx | 22 (39) | 24 (56) | |
Bilateral | 1(2) | 2 (5) | |
Histologic subtype | 0.088 | ||
Ductal | 42 (69) | 28 (68) | |
Lobular | 0 (0) | 3 (7) | |
Other subtype | 19 (31) | 10 (24) | |
Size (cm) | 0.78 | ||
≤ 2 cm | 31 (51) | 22 (54) | |
> 2 cm | 30 (49) | 19 (46) | |
pT | 0.75 | ||
T1-T2 | 54 (87) | 38 (91) | |
T3-T4 | 8 (13) | 4 (9) | |
pN | 0.407 | ||
N0-N1 | 47 (82) | 31 (76) | |
N2-N3 | 10 (18) | 10 (24) | |
Grade | 0.279 | ||
1 | 4 (6) | 2 (5) | |
2 | 13 (21) | 4 (9) | |
3 | 46 (73) | 36 (86) | |
Stage | 0.404 | ||
I | 13 (23) | 13 (33) | |
II | 30 (54) | 16 (40) | |
III | 13 (23) | 11 (27) | |
Necrosis | 0.188 | ||
Present | 24 (41) | 12 (29) | |
Absent | 34 (59) | 30 (71) | |
Tumor infiltrating lymphocyte | 0.082 | ||
Present | 21 (40) | 24 (58) | |
Absent | 31 (40) | 17 (42) | |
Lympho-vascular invasion | 0.255 | ||
Present | 18 (35) | 10 (24) | |
Absent | 34 (65) | 32 (76) | |
Margin's infiltration | 0.561 | ||
Present | 3 (8) | 1 (4) | |
Absent | 35 (92) | 23 (96) | |
Ki67 | 0.105 | ||
≤ 35% | 41 (67) | 21 (51) | |
> 35% | 20 (33) | 20 (49) | |
Androgen receptors | 0.854 | ||
Present | 18 (29) | 13 (30) | |
Absent | 45 (71) | 30 (70) | |
Surgery | 0.507 | ||
Mastectomy | 19 (35) | 12 (28) | |
Lumpectomy | 1 (2) | 2 (5) | |
Quadrantectomy | 31 (56) | 28 (65) | |
Combined | 4 (7) | 1 (2) | |
EGFR | < 0.0001 | ||
Positive | 50 (79) | 0 (0) | |
Negative | 13 (21) | 43 (100) | |
CK 5/6 | < 0.0001 | ||
Positive | 45 (71) | 0 (0) | |
Negative | 18 (29) | 43 (100) |
BLBC = Basal-like breast cancer
QNBC = Quintuple negative breast cancer
n = number
*The p-values are bold where they are less than or equal to the significance level of 0.05.